Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
Author(s) |
Date | Article Title | Journal |
|---|---|---|---|
|
Kaitlyn Johnson, Axel Gomez, Jackson Burton, Douglas White, Arijit Chakravarty, Annette Schmid, Dean Bottino |
November 2018 | Directional Inconsistency Between Response Evaluation Criteria in Solid Tumors (RECIST) Time to Progression and Response Speed and Depth | European Journal of Cancer |
|
Julia Wilkerson, Kald Abdallah, Charles Hugh-Jones, Greg Curt, Mace Rothenberg, Ronit Simantov, Martin Murphy, Joseph Morrell, Joel Beetsch, Daniel J. Sargent, Howard I. Scher, Peter Lebowitz,, Richard Simon, Wilfred D. Stein, Susan E. Bates, Tito Fojo |
January 2017 | Estimation of Tumour Regression and Growth Rates During Treatment in Patients with Advanced Prostate Cancer: A Retrospective Analysis | The Lancet Oncology |
|
Tomas G. Neilan, Mace L. Rothenberg, Laleh Amiri-Kordestani, Ryan J. Sullivan, Richard M. Steingart, William Gregory, Subramanian Hariharan, Tarek A. Hammad, Joann Lindenfeld, Martin J. Murphy, Javid Moslehi, On Behalf of the Checkpoint Inhibitor Safety Working Group |
May 2018 | Myocarditis Associated with Immune Checkpoint Inhibitors: an Expert Consensus on Data Gaps and a Call to Action | The Oncologist |
|
Thierry Wendling, Hitesh Mistry, Kayode Ogungbenro, Leon Aarons |
March 2016 | Predicting Survival of Pancreatic Cancer Patients Treated with Gemcitabine Using Longitudinal Tumour Size Data | Cancer Chemotherapy and Pharmacology |
|
Teemu D. Laajala, Mika Murtojārvi, Arho Virkki, Tero Aittokalio |
June 2018 | ePCR: An R-package for Survival Time and Time-to-Event Prediction in Advanced Prostate Cancer, Applied to Real-World Patient Cohorts | Bioinformatics |
|
S. Peter Wu, Moses Tam, Raymond Mailhot Vega, Carmen A. Perez, Naamit Kurshan Gerber |
November 2017 | Effect of Breast Irradiation on Cardiac Disease in Women Enrolled in BCIRG-001 at 10-Year Follow-Up | Radiation Oncology |
|
N. Geifman, A.J Butte |
May 2016 | A Patient-Level Data Meta-Analysis of Standard-of-Care Treatments from Eight Prostate Cancer Clinical Trials | Nature Scientific Data |
|
Hitesh B. Mistry |
November 2017 | On the relationship between tumour growth rate and survival in non-small cell lung cancer | PeerJ |
|
H-G Eichler, B Bloechl-Daum, P Bauer, F Bretz, J Brown, LV Hampson, P Honig, M Krams, H Leufkens, R Lim, MM Lumpkin, MJ Murphy, F Pignatti, M Posch, S Schneeweiss, M Trusheim, F Koenig |
September 2016 | “Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials? | Clinical Pharmacology & Therapeutics |
|
Fatemeh Seyednasrollah, Devin C. Koestler, Tao Wang, Stephen R. Piccolo, Roberto Vega, Russell Greiner, Christiane Fuchs, Eyal Gofer, Luke Kumar, Russell D. Wolfinger, Kimberly Kanigel Winner, Chris Bare, Elias Chaibub Neto, Thomas Yu, Liji Shen, Kald Abdallah, Thea Norman, Gustavo Stolovitzky, Howard R. Soule, Christopher J. Sweeney, Charles J. Ryan, Howard I. Scher, Oliver Sartor, Laura L. Elo, Fang Liz Zhou, Justin Guinney, James C. Costello, and Prostate Cancer DREAM Challenge Community |
August 2017 | A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer | Journal of Clinical Oncology |
|
Fadi S. Dahdaleh, Scott K. Sherman, Elizabeth C. Poli, Janani Vigneswaran, Blase N. Polite, Manish R. Sharma, Daniel V. Catenacci, Steven B. Maron, Kiran K. Turaga |
October 2018 | Obstruction Predicts Worse Long-term Outcomes in Stage III Colon Cancer: A Secondary Analysis of the N0147 Trial | Surgery |
|
Daniel E. Spratt, Yu-Wei Chen, Brandon A. Mahal, Joseph R. Osborne, Shuang G. Zhao, Todd M. Morgan, Ganesh Palapattu, Felix Y. Feng, Paul L. Nguyen |
March 2016 | Individual Patient Data Analysis of Randomized Clinical Trials: Impact of Black Race on Castration-resistant Prostate Cancer Outcomes | European Urology |
|
Bethany Pitcher, Leila Khoja, Robert J. Hamilton, Kald Abdallah, Melania Pintilie, Anthony M. Joshua |
February 2017 | Assessment of a Prognostic Model, PSA Metrics and Toxicities in Metastatic Castrate Resistant Prostate Cancer using Data from Project Data Sphere. | PLOS ONE |
|
Angela K. Green, Robert W. Corty, William A. Wood, Mathew Meeneghan, Katherine E. Reeder-Hayes, Ethan Basch, Matthew I Milowsky, Stacie B. Dusetzina |
May 2015 | Comparative Effectiveness of Mitoxantrone plus Prednisone versus Prednisone alone in Metastatic Castrate-resistant Prostate Cancer after Docetaxel Failure | The Oncologist |
